Mkts

Royalty Pharma plc

NASDAQ: RPRX
$67.30-0.27 (-0.40%)
As of Nov 6, 9:30 AM ET

Key statistics

Day range
66.5268.15
52-week range
37.3169.77
Today
Open66.52
Previous close67.30
Volume4.84M
Valuation
Market cap36.72B
P/E ratio45.06×
EPS (TTM)1.46
Income & risk
Dividend / yield0.65 / 2.96%
Beta0.38
Avg volume3.59M
Discussion

RPRX News

Stories mentioning RPRX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue630,576621,990609,291578,665568,247593,641564,690537,267
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development39,79050,50050,500300,50050,500500.00500.00500.00
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)563,038388,381427,156209,799534,182361,514735,074269,630
Interest Income
Interest Expense
Other Expense(2,201)(8,169)(1,575)(1,543)(3,062)(2,189)(1,654)6,000
Pretax Income468,256354,913444,21190,635434,433334,351806,358194,377
Tax Provision0.000.000.000.000.000.000.000.00
Net Income (Loss)294,690213,205288,21730,176239,349208,214543,987102,004
Earnings Per Share (Basic)0.670.500.670.070.550.461.220.23
Earnings Per Share (Diluted)0.670.380.670.070.550.351.210.23
Weighted Average Shares Outstanding (Basic)436,790429,801431,887423,514435,480448,185447,628451,020
Weighted Average Shares Outstanding (Diluted)556,837564,455559,611562,298578,102594,108592,726596,912

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About RPRX

Royalty Pharma plc (NASDAQ: RPRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol RPRX. It last traded at $67.30 (Nov 6, 2026, 9:30 AM ET), down 0.4% on the day. That gives Royalty Pharma a market capitalisation of $36.7B and a price-to-earnings ratio of 45.1.

Over the past 52 weeks RPRX has traded between $37.31 and $69.77.

Revenue for the quarter ended Mar 31, 2026 was $630.6M; net income $294.7M. Revenue was up 11.0% from $568.2M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$630.6M$294.7M46.7%
Dec 31, 2025$622.0M$213.2M34.3%
Sep 30, 2025$609.3M$288.2M47.3%
Jun 30, 2025$578.7M$30.2M5.2%

From Royalty Pharma’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…